Navigation Links
HeartWare International Announces Planned Departure of Chief Financial Officer
Date:10/27/2011

registered trademarks of HeartWare, Inc.

Forward-Looking Statements

This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management.  All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of, and presentation of data related to, clinical trials, expected timing of regulatory filings and approvals, research and development activities and changes in executive management. Management believes that these forward-looking statements are reasonable as and when made.  However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made.  HeartWare does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  HeartWare may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements.  Forward-looking statements are subject to a number of risks and uncertainties, including without limitation, the possibility the FDA does not accept our PMA application or approve the marketing of the HeartWare® Ventricular Assist System in the U.S., and those described in "Item 1A. Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission.  We may update our risk factors from time to time in "Part II, Item 1A "Risk Factors" in our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, or other filings with the Securities and Exchange Commission.

For further informa
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
2. HeartWare Announces Presentation of Clinical Data at the 25th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Lisbon
3. HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day
4. HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
5. HeartWare to Present at the Canaccord Genuity 31st Annual Growth Conference
6. HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010
7. HeartWare to Report Financial Results for Second Quarter of 2011
8. HeartWare to Present at the Wells Fargo 2011 Healthcare Conference
9. HeartWare to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
10. HeartWare International Reports First Quarter 2011 Revenues of $18.0 Million; 68% Increase From $10.7 Million in First Quarter 2010
11. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, the ... to announce that the Malcolm Campbell Memorial Prize ... (Vice President of Chemistry), Fiona Marshall (Chief Scientific ... Officer and co-founder) for the seminal contributions to GPCR drug ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
(Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... enables sustained,Interferon-beta production from muscle cells - ... disease, NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - ... at the American College of,Cardiology's 58th Annual ... DNA encoding the anti-inflammatory protein,interferon-beta (IFN-beta) using ...
... Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek,Pharmaceuticals Corporation ... clinical data demonstrating the safety of INO-1001,as ... a preventative agent for,cardiac reperfusion injury. The ... myocardial infarction (STEMI) undergoing,primary percutaneous coronary intervention. ...
Cached Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Yesterday, ... Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were honored ... leadership in advancing biotechnology, biomedical science, medical device ... Olsen each received the “2014 Life Sciences Champion” ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... , NEW YORK , Feb. ... Justice and Democracy: , A group of medical malpractice survivors, many ... a result of medical negligence, today sent letters to President Obama ... out of the health insurance reform bill.  They said that responding ...
... to attend school should not be given doctors, sick ... International (Dtsch Arztebl Int 2010; 107[4]), child and ... of school avoidance and describe measures to tackle the ... occurs frequently and is accompanied by psychiatric symptoms. Children ...
... tongue of a fruit fly could provide big answers to ... ways to treat obesity, according to a study from a ... the rank of Distinguished Professor of Biology, along with colleagues ... organs on Drosophila ,s proboscis (tongue), which triggers the ...
... AUGUSTA, Ga. Medical College of Georgia researchers are conducting ... of stem cells from umbilical cord blood can improve the ... The study will include 40 children age 2-12 whose parents ... Tucson, Ariz. Umbilical cord blood is rich in ...
... experts say drug has gotten ,bad rap, , THURSDAY, Feb. ... high risk of developing breast cancer take tamoxifen to prevent the ... have known since 1998 that tamoxifen can cut the risk of ... a surprise to me," said Dr. Jay Brooks, chairman of hematology/oncology ...
... lifesaving qualities, expert stresses , THURSDAY, Feb. 11 (HealthDay ... for three decades to treat the disease -- appears ... a new study has found. , "Our results are ... is known to be an important precondition for well-being," ...
Cached Medicine News:Health News:Medical Malpractice Survivors Urge President Obama to Keep 'Tort Reform' out of Health Insurance Bill 2Health News:Tiny fruit fly could offer big clues in fight against obesity, researcher says 2Health News:MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy 2Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 2Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 3Health News:Cognitive Skills May Shrink With Tamoxifen 2Health News:Cognitive Skills May Shrink With Tamoxifen 3
... peripheral nerve stimulator from B. Braun Medical. It ... advanced digital technology. , ,Your ability to ... the localization of practically all mixed nerves for ... additional optional component for the HNS11 is a ...
Based on the original MS-1 design the new MS-1B includes low battery detection, FET based output circuitry and enhanced battery compartment....
... allows hands-free operation in nerve locator mode., ... mA) with SoloStim provides a wide range ... when close to nerve., ,Supported by ... products, including the clinically proven ProBloc™ single ...
... The Aisys Carestation helps you deliver unmatched ... Aisys Carestation is the most complete anesthesia ... point of need - at your fingertips., ... our industry-leading Datex-Ohmeda legacy of anesthesia delivery ...
Medicine Products: